NO Whytee - I'm actually embarrased for you.
Heading refers to a pathway
Si's comments refer to an outcome after pathway completion which may be accelerated approval.
How about you provide negatives on the actual FDA comments as stated in the announcement
" the presented results may support a reasonable likelihood of clinical benefit......in LVAD patients, consistent with the criteria for accelerated approval"
When you are going to correct someone and give them a dressing down please be accurate.
Reg
NO Whytee - I'm actually embarrased for you.Heading refers to a...
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.030(2.29%) |
Mkt cap ! $1.461B | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $1.677M | 1.289M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 44452 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 23596 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |